Financials genedrive plc

Equities

EHP

GB00B1VKB244

Advanced Medical Equipment & Technology

Market Closed - London S.E. 11:35:19 2024-04-26 am EDT 5-day change 1st Jan Change
5.375 GBX -4.44% Intraday chart for genedrive plc -8.51% -33.85%

Valuation

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Capitalization 1 6.716 6.964 53.01 35.61 16.19 17.33
Enterprise Value (EV) 1 8.812 10.3 56.39 33.15 11.62 14.97
P/E ratio -1.13 x -1.46 x -1.85 x -46.9 x -3.18 x -3.18 x
Yield - - - - - -
Capitalization / Revenue 3.47 x 2.95 x 50.1 x 51.8 x 330 x 315 x
EV / Revenue 4.55 x 4.36 x 53.2 x 48.3 x 237 x 272 x
EV / EBITDA -2.07 x -2.37 x -10.1 x -6.11 x -2.09 x -2.9 x
EV / FCF -17.3 x -2.2 x -17.2 x -7.61 x -3.48 x -10.4 x
FCF Yield -5.78% -45.4% -5.83% -13.1% -28.7% -9.64%
Price to Book -2.77 x -2.81 x -15.9 x 9.92 x 2.89 x 8.49 x
Nbr of stocks (in thousands) 18,655 33,972 51,967 63,302 92,535 99,050
Reference price 2 0.3600 0.2050 1.020 0.5625 0.1750 0.1750
Announcement Date 12/12/18 11/6/19 11/27/20 11/16/21 12/5/22 12/6/23
1GBP in Million2GBP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net sales 1 1.938 2.362 1.059 0.687 0.049 0.055
EBITDA 1 -4.258 -4.351 -5.583 -5.422 -5.552 -5.163
EBIT 1 -5.264 -4.449 -5.64 -5.482 -5.615 -5.224
Operating Margin -271.62% -188.36% -532.58% -797.96% -11,459.18% -9,498.18%
Earnings before Tax (EBT) 1 -7.788 -4.518 -20.38 -1.852 -5.631 -5.981
Net income 1 -5.967 -3.636 -19.42 -0.691 -4.675 -5.15
Net margin -307.89% -153.94% -1,833.71% -100.58% -9,540.82% -9,363.64%
EPS 2 -0.3192 -0.1400 -0.5500 -0.0120 -0.0551 -0.0550
Free Cash Flow 1 -0.509 -4.671 -3.287 -4.355 -3.336 -1.443
FCF margin -26.26% -197.77% -310.39% -633.93% -6,808.93% -2,624.32%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 12/12/18 11/6/19 11/27/20 11/16/21 12/5/22 12/6/23
1GBP in Million2GBP
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 2.1 3.33 3.38 - - -
Net Cash position 1 - - - 2.46 4.57 2.36
Leverage (Debt/EBITDA) -0.4922 x -0.7663 x -0.6056 x - - -
Free Cash Flow 1 -0.51 -4.67 -3.29 -4.36 -3.34 -1.44
ROE (net income / shareholders' equity) -1,400% 148% 667% -553% -102% -135%
ROA (Net income/ Total Assets) -36.6% -42.2% -39.8% -44.7% -61% -58.7%
Assets 1 16.28 8.607 48.78 1.546 7.659 8.776
Book Value Per Share 2 -0.1300 -0.0700 -0.0600 0.0600 0.0600 0.0200
Cash Flow per Share 2 0.1900 0.1500 0.1600 0.0400 0.0500 0.0300
Capex 1 0.02 0.1 0.04 0.1 0.06 0.05
Capex / Sales 1.24% 4.11% 3.78% 15.14% 126.53% 94.55%
Announcement Date 12/12/18 11/6/19 11/27/20 11/16/21 12/5/22 12/6/23
1GBP in Million2GBP
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Chiffre d''affaires - Rate of surprise

  1. Stock Market
  2. Equities
  3. EHP Stock
  4. Financials genedrive plc